ArticlePharmaceuticals (Basel, Switzerland)2023

Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib.

Vera Stoeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.